|
Symbol Name ID |
Slc2a1
solute carrier family 2 (facilitated glucose transporter), member 1 MGI:95755 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Slc2a1em1Mase/Slc2a1em1Mase involves: C57BL/6N |
postnatal lethality, complete penetrance | J:308608 |
| Slc2a1Rgsc200/Slc2a1+ involves: C57BL/6JJcl * DBA/2JJcl |
ataxia | J:133634 |
| impaired passive avoidance behavior | J:133634 | |
| no spontaneous movement | J:133634 | |
| Slc2a1tm1Dcdv/Slc2a1+ involves: 129S6/SvEvTac * C57BL/6J |
abnormal glucose homeostasis | J:108250 |
| abnormal motor capabilities/coordination/movement | J:108250 | |
| decreased brain weight | J:108250 | |
| decreased cellular glucose uptake | J:108250 | |
| impaired coordination | J:108250 | |
| sporadic seizures | J:108250 | |
| Slc2a1tm1Dcdv/Slc2a1tm1Dcdv involves: 129S6/SvEvTac * C57BL/6J |
decreased embryo size | J:108250 |
| embryonic growth retardation | J:108250 | |
| embryonic lethality during organogenesis, complete penetrance | J:108250 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/16/2024 MGI 6.23 |
|
|
|
||
Analysis Tools